Blood pressure pill showdown pulled before it began
NCT ID NCT02483936
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to compare two different combination pills for controlling high blood pressure: one with olmesartan and chlorthalidone, and another with olmesartan and hydrochlorothiazide (Benicar HCT). The trial was planned for people with uncontrolled hypertension but was withdrawn before any participants were enrolled. No results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- olmesartan medoxomil + chlorthalidone
- What this could lead to
- If successful, this could offer a new fixed-dose combination pill for controlling high blood pressure.
- What could go wrong
- The trial was withdrawn before enrolling any participants, so no results are available. It is unclear if the combination would have been safer or more effective than existing options.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple blood pressure target during surgery prevent delirium in older patients?
- Forest bathing and meditation tested as natural blood pressure aids for women over 60
- Phone calls from nurses aim to tame high blood pressure in women
- Gut feeling: personalized bacteria may ease PTSD symptoms
- Gum disease may worsen high blood pressure, new study suggests
- New study aims to uncover hidden kidney disease in rural africa